What Factors Impact Implementation of Critical Incident Disclosure in Ontario Hospitals: A Multiple-Case Study.


Journal

Healthcare policy = Politiques de sante
ISSN: 1715-6580
Titre abrégé: Healthc Policy
Pays: Canada
ID NLM: 101280107

Informations de publication

Date de publication:
02 2021
Historique:
entrez: 15 3 2021
pubmed: 16 3 2021
medline: 26 10 2021
Statut: ppublish

Résumé

Guidelines and legislation prescribe how hospitals should conduct critical incident disclosures with patients. However, variation in secondary disclosure implementation can occur. Using the Consolidated Framework for Implementation Research, this qualitative multiple-case study explored the factors that impact Ontario hospitals' secondary disclosure of critical incidents. The study concludes that while hospitals generally implement guidelines consistently, complex environments and differing professional backgrounds lead to variations. Consequently, hospitals should address timing delays, improve documentation and enhance support to clinicians who conduct the disclosures. Policy makers should consider the benefits and challenges of written disclosure, and offering patients a choice in the setting where disclosure occurs, as potential improvements.

Identifiants

pubmed: 33720826
pii: hcpol.2021.26431
doi: 10.12927/hcpol.2021.26431
pmc: PMC7957351
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-88

Informations de copyright

Copyright © 2021 Longwoods Publishing.

Références

J Public Health Res. 2013 Dec 01;2(3):e32
pubmed: 25170503
J Eval Clin Pract. 2017 Aug;23(4):713-718
pubmed: 28220984
J Patient Saf. 2017 Dec;13(4):243-248
pubmed: 25706909
Best Pract Res Clin Anaesthesiol. 2011 Jun;25(2):169-79
pubmed: 21550542
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
N Engl J Med. 2007 Jun 28;356(26):2713-9
pubmed: 17596606
Clin Biochem. 2013 Sep;46(13-14):1161-9
pubmed: 23578740
Arch Intern Med. 2009 Nov 9;169(20):1888-94
pubmed: 19901141
Arch Intern Med. 2006 Aug 14-28;166(15):1585-93
pubmed: 16908791
Int J Qual Health Care. 2010 Oct;22(5):371-9
pubmed: 20709703
Jt Comm J Qual Patient Saf. 2011 Sep;37(9):409-17
pubmed: 21995257

Auteurs

Michael Heenan (M)

PhD Candidate, Business Administration (Health Management), DeGroote School of Business, McMaster University, Hamilton, ON.

Gillian Mulvale (G)

Associate Professor, Health Policy and Management, DeGroote School of Business, McMaster University; Member, Centre for Health Economics & Policy Analysis; Member, Michael G. DeGroote Health Leadership Academy, Hamilton, ON.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH